Niki BioSolutions, through its subsidiary DiamiR Biosciences, will present a poster on their APOE genotype testing method using dried blood spots at the 19th Clinical Trials on Alzheimer’s Disease (CTAD) conference in Boston on November 19, 2026. This testing, validated in their CLIA-certified lab and approved by the New York State Department of Health, offers a quick and minimally invasive way to assess genetic risk factors for Alzheimer’s. The presentation highlights advances in Alzheimer’s diagnostics, supporting research and clinical collaboration in this rapidly evolving field.
Niki BioSolutions' presentation at the CTAD 2026 conference provides context for readers interested in health-sector trends. For readers following Health-sector US stocks on Pluang, here is the market snapshot as of Nov 09, 2026 23:12 WIB: out of 150 priced stocks, 118 rose and 32 fell. RXRX led with a price of USD 3.83 and an 8.81% increase, outperforming MRVI at USD 8.12 with a 7.98% rise, and ALMS at USD 6.51 with a 7.96% gain. Typical hold times ranged from 15 to 25 days among these top movers.
Nokia Corporation transferred 847,057 of its own shares to participants of its equity-based incentive plans without any payment, following a board resolution. This transfer fulfills Nokia's commitments under these plans and reduces the company's own ...
Nokia has transferred 847,057 of its treasury shares to employees participating in its stock-based incentive programs, as per a board decision announced in October 2025. This transfer was done without compensation, fulfilling commitments under the in...
Silvercrest Asset Management Group Inc. was ranked #8 in Nasdaq eVestment’s Q3 2026 Brand Awareness Rankings among mid-sized firms managing $2.5 billion to $40 billion in assets. This ranking reflects strong engagement from consultants and asset owne...
The Software Safety Institute (SSI), a new independent nonprofit, has launched to tackle preventable harm caused by unsafe and insecure software. SSI aims to improve software safety by changing industry incentives and practices through research, publ...
AST SpaceMobile is set to report its Q3 2026 earnings with an expected loss of $0.42 per share and revenue of $45.7 million. The company is advancing its satellite network technology, including a new joint venture with Rakuten to build a direct-to-de...
